• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反流症状和 GORD 的流行病学。

Epidemiology of reflux symptoms and GORD.

机构信息

Primary Health Care Center, Tornio, Finland.

出版信息

Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):325-37. doi: 10.1016/j.bpg.2013.06.008.

DOI:10.1016/j.bpg.2013.06.008
PMID:23998972
Abstract

Gastro-oesophageal reflux disease (GORD) occurs when reflux of gastric contents causes troublesome symptoms and/or complications (the Montreal definition). GORD is a common condition with a substantial economical burden to the community and it has a significant negative effect on health-related quality of life (HRQoL) while endoscopic findings like erosive oesophagitis per se seem to correlate badly with the experienced HRQoL. The prevalence of GORD varies over the world for unknown reasons, but genetic differences, difference in the Helicobacter pylori prevalence and life style factors like obesity might influence. The prevalence is lowest in East Asia (2.5-9.4%) and higher in Mid (7.6-19.4%) and Western Asia (12.5-27.6%). The highest population-based prevalence is reported from Europe (23.7%) and the US (28.8%). GORD seems to be fairly stable over time both in terms of symptoms and erosive oesophagitis, but the prevalence seems to be increasing both in Asia and in the West.

摘要

胃食管反流病(GORD)是指胃内容物反流引起不适症状和/或并发症(蒙特利尔定义)。GORD 是一种常见疾病,给社区带来了巨大的经济负担,它对健康相关生活质量(HRQoL)有显著的负面影响,而内镜下发现的食管炎本身似乎与所经历的 HRQoL 相关性较差。由于未知原因,GORD 在世界各地的患病率不同,但遗传差异、幽门螺杆菌流行率的差异以及肥胖等生活方式因素可能会产生影响。在东亚(2.5-9.4%),GORD 的患病率最低,在中东(7.6-19.4%)和西亚(12.5-27.6%)则较高。基于人群的最高患病率报道来自欧洲(23.7%)和美国(28.8%)。无论是症状还是糜烂性食管炎,GORD 在一段时间内似乎都相当稳定,但在亚洲和西方,其患病率似乎都在上升。

相似文献

1
Epidemiology of reflux symptoms and GORD.反流症状和 GORD 的流行病学。
Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):325-37. doi: 10.1016/j.bpg.2013.06.008.
2
Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.白细胞介素1B促炎基因型通过诱导胃体萎缩预防胃食管反流病。
Gut. 2006 Feb;55(2):158-64. doi: 10.1136/gut.2005.072942. Epub 2005 Aug 24.
3
Reflux disease: the disorder of the third millennium.反流性疾病:第三个千年的病症。
Eur J Gastroenterol Hepatol. 2001 May;13 Suppl 1:S5-11.
4
Gastro-oesophageal reflux disease in Asia : birth of a 'new' disease?亚洲的胃食管反流病:一种“新”疾病的诞生?
Drugs. 2008;68(4):399-406. doi: 10.2165/00003495-200868040-00001.
5
Is there a relationship between Helicobacter pylori infection and erosive reflux disease in children?儿童幽门螺杆菌感染与反流性食管炎是否有关?
Acta Paediatr. 2010 Jan;99(1):121-5. doi: 10.1111/j.1651-2227.2009.01512.x.
6
cagA-positive Helicobacter pylori strains and gastro-oesophageal reflux disease: still puzzling?细胞毒素相关基因A阳性幽门螺杆菌菌株与胃食管反流病:仍令人困惑?
Eur J Gastroenterol Hepatol. 2004 Jul;16(7):635-7. doi: 10.1097/01.meg.0000108354.41221.3e.
7
Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.巴雷特食管和幽门螺杆菌感染对糜烂性胃食管反流病(GORD)愈合及非糜烂性GORD症状缓解的预后影响:来自ProGORD研究的报告
Gut. 2005 Jun;54(6):746-51. doi: 10.1136/gut.2004.042143.
8
Improving the diagnosis and management of GORD in adults.改善成人胃食管反流病的诊断与管理。
Practitioner. 2015 Apr;259(1781):27-32, 3.
9
Complications of gastro-oesophageal reflux disease.胃食管反流病的并发症。
Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):433-42. doi: 10.1016/j.bpg.2013.07.002.
10
Epidemiology of gastro-oesophageal reflux disease: a systematic review.胃食管反流病的流行病学:一项系统综述。
Gut. 2005 May;54(5):710-7. doi: 10.1136/gut.2004.051821.

引用本文的文献

1
Approach to Patients with Dysphagia: Clinical Insights.吞咽困难患者的诊疗方法:临床见解
Brain Sci. 2025 Apr 30;15(5):478. doi: 10.3390/brainsci15050478.
2
Gastric acid challenge of lithium disilicate-reinforced glass-ceramics and zirconia-reinforced lithium silicate glass-ceramic after polishing and glazing-impact on surface properties.锂硅玻璃陶瓷和氧化锆增强锂硅玻璃陶瓷抛光和上釉后的胃酸挑战——对表面性能的影响。
Clin Oral Investig. 2023 Nov;27(11):6865-6877. doi: 10.1007/s00784-023-05301-x. Epub 2023 Oct 11.
3
Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of disease study 2019.
204 个国家和地区 1990-2019 年胃食管反流病负担:2019 年全球疾病负担研究的系统分析。
BMC Public Health. 2023 Mar 29;23(1):582. doi: 10.1186/s12889-023-15272-z.
4
The Lyon Consensus Criteria for GERD Diagnosis in a Greek Population: The Clinical Impact and Changes in GERD Diagnosis in a Real-World, Retrospective Study.希腊人群中GERD诊断的里昂共识标准:一项真实世界回顾性研究中GERD诊断的临床影响及变化
J Clin Med. 2022 Sep 14;11(18):5383. doi: 10.3390/jcm11185383.
5
Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms.代谢功能障碍相关脂肪性肝病增加胃食管反流症状的风险。
Diabetes Metab Syndr Obes. 2022 Jan 20;15:199-207. doi: 10.2147/DMSO.S339428. eCollection 2022.
6
Relationship of meteorological factors and air pollutants with medical care utilization for gastroesophageal reflux disease in urban area.气象因素和空气污染物与城市地区胃食管反流病医疗利用的关系。
World J Gastroenterol. 2020 Oct 21;26(39):6074-6086. doi: 10.3748/wjg.v26.i39.6074.
7
The Lyon Consensus: Does It Differ From the Previous Ones?《里昂共识:它与之前的共识有何不同?》
J Neurogastroenterol Motil. 2020 Jul 30;26(3):311-321. doi: 10.5056/jnm20046.
8
Idiopathic pulmonary fibrosis and GERD: links and risks.特发性肺纤维化与胃食管反流病:关联与风险
Ther Clin Risk Manag. 2019 Sep 5;15:1081-1093. doi: 10.2147/TCRM.S184291. eCollection 2019.
9
Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy.接受质子泵抑制剂治疗的胃食管反流病退伍军人对以患者为中心的护理的认知
Patient Exp J. 2018;5(3):149-159. doi: 10.35680/2372-0247.1232.
10
Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients.质子泵抑制剂治疗对通过粪便钙卫蛋白评估的儿科患者肠道炎症的影响。
Korean J Pediatr. 2019 Oct;62(10):400-404. doi: 10.3345/kjp.2019.00115. Epub 2019 Jul 3.